Answer
The most common adverse reaction to eculizumab was headache, occurring mostly in the initial phase of dosing.
Sources for this answer
- Soliris 300 mg concentrate for solution for infusionAlexion Pharma UK Ltd · emc · SmPC §4.8 Undesirable effects · Version 29Document updated
Sources checked